ClinicalTrials.Veeva

Menu

Silicone Oil Tamponade for Vitrectomy of Hypermyopic Foveoschisis.

P

Peking University

Status

Enrolling

Conditions

Hypermyopic Foveoschisis

Treatments

Procedure: PPV with fovea-sparing ILMP and gas tamponade
Procedure: PPV with gas tamponade
Procedure: PPV with SO tamponade

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to explore the efficiency and safety of the surgical procedure of pars plana vitrectomy with silicone oil tamponade and without internal limiting membrane peeling for myopic foveoschisis eyes with high risk of macular hole formation.

Enrollment

159 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with spherical ≥ -8 diopters or axial length ≥ 26.5mm.
  • The foveoshisis combined with foveal detachment was showed on the OCT image. The foveal detachment height≥ 250 um ,and the thickness of sensory retina of foveal detachment was ≤100 um;
  • patients signed the ICF.
  • patients with BCVA ≤0.5,and with visual disturbance symptoms.

Exclusion criteria

  • patients with macular hole
  • accompanied or secondary of other fundus disease
  • received vitrectomy due to other diseases
  • glaucoma cannot be controled by medication
  • patients with other retinal or choroidal disease that may affect VA
  • poor patients compliance
  • poor condition that cannot undertake the surgery
  • optical opacities which make it difficult to exam fundus or measure on OCT

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

159 participants in 3 patient groups

Silicone oil group
Experimental group
Description:
Patients randomized into this group were received pars plana vitrectomy surgery with silicone oil tamponade and without internal limiting membrane peeling. And silicone oil tamponade was removed at least 12 months after the primary surgery with completely resolved of foveoschisis.
Treatment:
Procedure: PPV with SO tamponade
Gas group 1
Active Comparator group
Description:
Patients randomized into this group were received pars plana vitrectomy surgery with fovea-sparing internal limiting membrane peeling and gas tamponade.
Treatment:
Procedure: PPV with fovea-sparing ILMP and gas tamponade
Gas group 2
Active Comparator group
Description:
Patients randomized into this group were received pars plana vitrectomy surgery with gas tamponade and without internal limiting membrane peeling.
Treatment:
Procedure: PPV with gas tamponade

Trial contacts and locations

1

Loading...

Central trial contact

Mingwei Zhao, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems